{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:44:17Z","timestamp":1781127857769,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ctro.2023.100676","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T11:33:16Z","timestamp":1694950396000},"page":"100676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Adaptive FDG-PET\/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)"],"prefix":"10.1016","volume":"43","author":[{"given":"Abrahim","family":"Al-Mamgani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Kessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-6839","authenticated-orcid":false,"given":"Zeno A.R.","family":"Gouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-7807","authenticated-orcid":false,"given":"Arash","family":"Navran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3947-5575","authenticated-orcid":false,"given":"Vineet","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen B.","family":"van de Kamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Jakob","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter V.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2023.100676_b0005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"Haddad","year":"2008","journal-title":"N Eng J Med"},{"issue":"1","key":"10.1016\/j.ctro.2023.100676_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100676_b0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2023.100676_b0020","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2023.100676_b0025","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ijrobp.2020.04.030","article-title":"Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer","volume":"108","author":"Gouw","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2023.100676_b0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2022.03.021","article-title":"Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET\/CT","volume":"171","author":"Welz","year":"2022","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2023.100676_b0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2010.03.028","article-title":"Adaptive Dose Painting by Numbers for Head-and-Neck Cancer","volume":"80","author":"Duprez","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.ctro.2023.100676_b0040","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/hed.24892","article-title":"Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study","volume":"39","author":"Berwouts","year":"2017","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.ctro.2023.100676_b0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2013.04.002","article-title":"Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial","volume":"107","author":"Berwouts","year":"2013","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100676_b0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2016.03.005","article-title":"Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer","volume":"120","author":"Rasmussen","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100676_b0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100676_b0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2011.08.009","article-title":"Predictive modelling for swallowing dysfunction after primary (chemo) radiation: Results of a prospective observational study","volume":"105","author":"Christianen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2023.100676_b0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijrobp.2009.04.087","article-title":"NTCP modeling of subacute\/late laryngeal edema scored by fiberoptic examination","volume":"75","author":"Rancati","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2023.100676_b0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2023.100676_b0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.08.018","article-title":"Revisiting the dose constraints for head and neck OARs in the current era of IMRT","volume":"86","author":"Brodin","year":"2018","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100676_b0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","article-title":"Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer","volume":"105","author":"Zips","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100676_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-84","article-title":"Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer","volume":"13","author":"Heukelom","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2023.100676_b0090","unstructured":"clinicaltrials.gov identifier NCT01341535."},{"issue":"3","key":"10.1016\/j.ctro.2023.100676_b0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.radonc.2017.08.010","article-title":"Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging","volume":"124","author":"L\u00f6ck","year":"2017","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2023.100676_b0100","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djaa184","article-title":"Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial","volume":"113","author":"Riaz","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ctro.2023.100676_b0105","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s00259-021-05610-x","article-title":"[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma","volume":"49","author":"Vos","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"23","key":"10.1016\/j.ctro.2023.100676_b0110","first-page":"00284","article-title":"Initial Feasibility and Acute Toxicity Outcomes from a Phase II trial of FDG-PET response-based de-escalated definitive chemoradiotherapy for p16+ oropharynx cancer, a Planned Interim Analysis","volume":"S0360\u20133016","author":"Allen","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:11:37Z","timestamp":1762503097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"alternative-id":["S2405630823001015"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100676","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptive FDG-PET\/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100676"}}